Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Rheumatology (Oxford, England)
|
December 10, 2024
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study
Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
The Lancet. Rheumatology
|
January 22, 2024
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study
Jiacai Cho, Liang Shen, Molla Huq, et al.
The Journal of Rheumatology
|
March 15, 2024
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus
Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Lupus Science & Medicine
|
November 11, 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study
Rangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, et al.
Arthritis Research & Therapy
|
July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort
Rangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Rheumatology (Oxford, England)
|
May 19, 2023
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring
Ai Li Yeo, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 19, 2022
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study
Kathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Arthritis Care & Research
|
April 6, 2026
Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort study
Amanda M Saracino, Yanjie Hao, Dylan Hansen, et al.
The Lancet. Rheumatology
|
January 23, 2024
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study
Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
Lupus Science & Medicine
|
May 6, 2025
Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study
Kathryn Connelly, Rachel Koelmeyer, Darshini Ayton, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Rheumatology (Oxford, England)
|
December 10, 2024
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort study
Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
The Lancet. Rheumatology
|
January 22, 2024
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort study
Jiacai Cho, Liang Shen, Molla Huq, et al.
The Journal of Rheumatology
|
March 15, 2024
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus Erythematosus
Vera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Lupus Science & Medicine
|
November 11, 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort study
Rangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, et al.
Arthritis Research & Therapy
|
July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohort
Rangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Rheumatology (Oxford, England)
|
May 19, 2023
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring
Ai Li Yeo, Rangi Kandane-Rathnayake, Rachel Koelmeyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
September 19, 2022
Association of Modified Systemic Lupus Erythematosus Responder Index Attainment With Long-Term Clinical Outcomes: A Five-Year Prospective Study
Kathryn Connelly, Rangi Kandane-Rathnayake, Alberta Hoi, et al.
Arthritis Care & Research
|
April 6, 2026
Mucocutaneous disease activity and damage accrual in systemic lupus erythematosus: analyses from the Asia-Pacific Lupus Collaboration longitudinal cohort study
Amanda M Saracino, Yanjie Hao, Dylan Hansen, et al.
The Lancet. Rheumatology
|
January 23, 2024
Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study
Rangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
Lupus Science & Medicine
|
May 6, 2025
Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study
Kathryn Connelly, Rachel Koelmeyer, Darshini Ayton, et al.
Page
of 5